Medtronic plc Stock
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | -1.060% | -0.985% | -3.965% | 0.964% | -9.361% | 1.115% | -27.454% |
| Dexcom Inc. | -3.200% | 1.224% | -6.475% | -9.121% | -4.745% | -46.990% | -32.068% |
| Teleflex Inc. | -1.260% | 0.098% | 6.354% | -14.917% | 0.098% | -56.737% | -71.320% |
| Baxter International | 0.780% | 1.051% | -2.728% | -41.765% | -10.263% | -62.271% | -79.507% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as investors analyzed new clinical trial
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure
Artificial intelligence (AI) has been the hottest thing on Wall Street over the past three years. Many believe the technology is here to stay and will make those who pick the right stocks
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $1,000
Most investors don't associate the healthcare sector with dividends, but there are some pretty impressive dividend stocks to be had. Two that stand out today are Becton, Dickinson (NYSE: BDX) and